Based on controlling extracellular purinergic gradient, the reduction in CD39 activity can have a number of consequences in CAVD development, particularly associated with thrombosis and inflammation. Here, ENTPD1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.